Rifana®

Brand name: Arena Life Science

Generic Name: Warfarin

Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S

Pharmaceutical Class: Anticoagulant

Dosage Form and Strength: Tablet, Oral (5 mg)

Product Description:

Indications:

  • Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).
  • Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement.
  • Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Additional Information

Additional information

Related Products

Rifana®

View Product

Product Images

rifana-warfarin-1 rifana-warfarin-2 rifana-warfarin